Mietingen, Germany

Ursula Springmeier


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 35(Granted Patents)


Company Filing History:


Years Active: 1986-1987

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Ursula Springmeier

Introduction

Ursula Springmeier is a notable inventor based in Mietingen, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for cardiovascular disorders and related conditions. With a total of 2 patents, her work has the potential to impact many lives.

Latest Patents

One of her latest patents is focused on an oral mopidamol preparation. This invention relates to vehicles for the administration of mopidamol, specifically targeting the treatment of cardiovascular disorders, malignancy, or thrombosis. The method involves administering a composition that includes mopidamol or an acid addition salt, combined with at least one pharmacologically acceptable acid or acid substance. The ratio of acid to mopidamol is crucial, ensuring effective treatment for those in need.

Career Highlights

Ursula Springmeier is associated with Dr. Karl Thomae GmbH, where she has been able to apply her innovative ideas in a professional setting. Her work has garnered attention for its potential to improve therapeutic outcomes in patients suffering from serious health conditions.

Collaborations

Throughout her career, Ursula has collaborated with esteemed colleagues such as Gottfried Schepky and Rolf Stefan Brickl. These partnerships have likely contributed to the advancement of her research and the successful development of her patents.

Conclusion

Ursula Springmeier's contributions to the field of pharmaceuticals exemplify the impact of innovation in healthcare. Her patents and collaborative efforts highlight the importance of research in developing effective treatments for critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…